These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33726654)

  • 1. The Potential Role of Peritumoral Apparent Diffusion Coefficient Evaluation in Differentiating Glioblastoma and Solitary Metastatic Lesions of the Brain.
    Tepe M; Saylisoy S; Toprak U; Inan I
    Curr Med Imaging; 2021; 17(10):1200-1208. PubMed ID: 33726654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gradient of apparent diffusion coefficient values in peritumoral edema helps in differentiation of glioblastoma from solitary metastatic lesions.
    Lemercier P; Paz Maya S; Patrie JT; Flors L; Leiva-Salinas C
    AJR Am J Roentgenol; 2014 Jul; 203(1):163-9. PubMed ID: 24951211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions.
    Lee EJ; terBrugge K; Mikulis D; Choi DS; Bae JM; Lee SK; Moon SY
    AJR Am J Roentgenol; 2011 Jan; 196(1):71-6. PubMed ID: 21178049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging.
    Ko CC; Tai MH; Li CF; Chen TY; Chen JH; Shu G; Kuo YT; Lee YC
    PLoS One; 2016; 11(9):e0162565. PubMed ID: 27631626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring early responses to neoadjuvant chemotherapy and the factors affecting neoadjuvant chemotherapy responses in primary osteosarcoma.
    Yu H; Gao L; Shi R; Kong M; Duan L; Cui J
    Quant Imaging Med Surg; 2023 Jun; 13(6):3716-3725. PubMed ID: 37284107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
    Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
    J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results.
    Baunin C; Schmidt G; Baumstarck K; Bouvier C; Gentet JC; Aschero A; Ruocco A; Bourlière B; Gorincour G; Desvignes C; Colavolpe N; Bollini G; Auqier P; Petit P
    Skeletal Radiol; 2012 Sep; 41(9):1141-9. PubMed ID: 22318350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of apparent diffusion coefficient in differentiating between high-grade gliomas and brain metastases.
    Caravan I; Ciortea CA; Contis A; Lebovici A
    Acta Radiol; 2018 May; 59(5):599-605. PubMed ID: 28835111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of Minimum Apparent Diffusion Coefficient in Peritumoral Edema in the Differential Diagnosis between Primary Central Nervous System Lymphoma and Glioblastoma].
    Li MG; Chen ZY; Liu G; Xiao HF; Chen XJ; Lou X; Ma L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Apr; 40(2):146-150. PubMed ID: 29724302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of apparent diffusion coefficient in differentiation of glioblastoma from metastasis.
    Beig Zali S; Alinezhad F; Ranjkesh M; Daghighi MH; Poureisa M
    Neuroradiol J; 2021 Jun; 34(3):205-212. PubMed ID: 33417503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
    Neska-Matuszewska M; Bladowska J; Sąsiadek M; Zimny A
    PLoS One; 2018; 13(1):e0191341. PubMed ID: 29342201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of conventional magnetic resonance imaging and diffusion-weighted imaging in the differentiation of bone plasmacytoma from bone metastasis in the extremities.
    Hwang H; Lee SK; Kim JY
    Diagn Interv Imaging; 2021 Oct; 102(10):611-618. PubMed ID: 34127433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging.
    Toh CH; Castillo M; Wong AM; Wei KC; Wong HF; Ng SH; Wan YL
    AJNR Am J Neuroradiol; 2008 Mar; 29(3):471-5. PubMed ID: 18065516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T.
    Tsougos I; Svolos P; Kousi E; Fountas K; Theodorou K; Fezoulidis I; Kapsalaki E
    Cancer Imaging; 2012 Oct; 12(3):423-36. PubMed ID: 23108208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the apparent diffusion coefficient for the evaluation of the white matter to differentiate between glioblastoma and brain metastases.
    Miquelini LA; Pérez Akly MS; Funes JA; Besada CH
    Radiologia; 2016; 58(3):207-13. PubMed ID: 26655126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
    Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
    Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a high b-value for diffusion weighted imaging of peritumoral regions to differentiate high-grade gliomas and solitary metastases.
    Han C; Huang S; Guo J; Zhuang X; Han H
    J Magn Reson Imaging; 2015 Jul; 42(1):80-6. PubMed ID: 25223489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.